Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BIO-TECHNE Corp    TECH

BIO-TECHNE CORP

(TECH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Bio Techne : Appoints Rupert Vessey to Board of Directors

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 04:06pm EDT

MINNEAPOLIS, June 25, 2019 /PRNewswire/ -- Bio-Techne Corporation today announced the appointment of Dr. Rupert Vessey to the company's Board of Directors as an independent director.  Dr. Vessey's appointment brings the total number of Bio-Techne Board members to nine.

Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research and Early Development at Celgene, and is anticipated to hold that position at Bristol-Myers Squibb once its acquisition of Celgene is final.  Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Prior to his ten years at Merck, Dr. Vessey worked in drug discovery, experimental medicine, and early clinical development at GlaxoSmithKline. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK. 

"We are pleased to welcome Rupert to our board," said Bob Baumgartner, chairman of the board of Bio-Techne. "With his extensive experience in the pharmaceutical and biotech industry, his perspective will be highly valuable as we continue to build on Bio-Techne's industry-leading capabilities for both research and clinical customers."

About Bio-Techne Corporation (NASDAQ: TECH)

 

Contact: David Clair, Investor Relations

ir@bio-techne.com 

646-277-1266

Bio-Techne

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-appoints-rupert-vessey-to-board-of-directors-300874559.html

SOURCE Bio-Techne Corporation


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIO-TECHNE CORP
07/18BIO TECHNE : To Host Conference Call On August 6, 2019, To Announce Fourth Quart..
PR
07/17BIO TECHNE : Releases 32x8 Cartridge For The Ella Platform
PR
07/11BIO-TECHNE ANNOUNCES COMMERCIAL RELE : A Multiplex In Situ Hybridization Assay F..
PR
07/09BIO TECHNE : CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The ..
PR
06/26BIO TECHNE : China Recognized With "Decade of Contribution Award"
PR
06/25BIO-TECHNE CORP : Change in Directors or Principal Officers, Other Events, Finan..
AQ
06/25BIO TECHNE : Appoints Rupert Vessey to Board of Directors
PR
06/17BIO TECHNE : FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx&tr..
PR
06/13BIO TECHNE : Receives Approval To Offer The ExoDx™ Prostate Intelliscore&t..
PR
06/04BIO TECHNE : To Acquire B-MoGen Biotechnologies Inc.
PR
More news